IRONWOOD PHARMACEUTICALS INC (IRWD) is a publicly traded company in the Unknown sector. Across all available filings, 46 corporate insiders have executed 1007 transactions totaling $153.9M, demonstrating a bearish sentiment with -$105.7M in net insider flow. The most recent transaction on Dec 15, 2025 involved a transaction of 4,178 shares valued at $0.
No significant insider buying has been recorded for IRWD in the recent period.
No significant insider selling has been recorded for IRWD in the recent period.
Based on recent SEC filings, insider sentiment for IRWD is bearish with an Insider Alignment Score of 16/100 and a net flow of -$105.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at IRONWOOD PHARMACEUTICALS INC (IRWD) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 46 insiders are actively trading IRWD stock, having executed 1007 transactions in the past 90 days. The most active insider is Mark G. Currie (Executive), who has made 80 transactions totaling $31.1M.
Get notified when executives and directors at IRWD file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | J. Denner Alexander | Executive | Award | 4,178 | $N/A | $0 | |
| Nov 17, 2025 | L. Gaskins Tammi | Executive | Sale | 6,016 | $3.32 | $20.0K | |
| Sep 15, 2025 | J. Denner Alexander | Executive | Award | 11,718 | $N/A | $0 | |
| Aug 11, 2025 | S. Martini Gregory | Executive | Sale | 1,265 | $0.84 | $1.1K | |
| Aug 11, 2025 | Silver Ronald | Executive | Sale | 2,846 | $0.84 | $2.4K | |
| Aug 11, 2025 | John Minardo | Executive | Sale | 7,754 | $0.84 | $6.5K | |
| Aug 11, 2025 | L. Gaskins Tammi | Executive | Sale | 1,316 | $0.84 | $1.1K | |
| Sep 16, 2024 | Management Lp Sarissa Capital | Executive | Award | 3,282 | $N/A | $0 | |
| Aug 12, 2024 | Silver Ronald | Executive | Sale | 3,107 | $4.27 | $13.3K | |
| Aug 12, 2024 | John Minardo | Executive | Sale | 9,910 | $4.27 | $42.3K | |
| Jun 18, 2024 | L. Kessler Marla | Executive | Award | 24,311 | $N/A | $0 | |
| Jun 18, 2024 | R. Duane Jon | Executive | Award | 24,311 | $N/A | $0 | |
| Jun 18, 2024 | G. Currie Mark | Executive | Award | 24,311 | $N/A | $0 | |
| Jun 18, 2024 | Mchugh Julie | Executive | Award | 24,311 | $N/A | $0 | |
| Jun 18, 2024 | Dreyfus Andrew | Executive | Award | 24,311 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 421 | $129.8M | 74.7% |
Purchase(P) | 16 | $24.1M | 13.9% |
Exercise(M) | 106 | $18.1M | 10.4% |
Payment(F) | 4 | $1.8M | 1.0% |
Award(A) | 324 | $34.1K | 0.0% |
Gift(G) | 34 | $0 | 0.0% |
Disposition(D) | 5 | $0 | 0.0% |
Other(J) | 78 | $0 | 0.0% |
Conversion(C) | 19 | $0 | 0.0% |
Insider selling pressure at IRONWOOD PHARMACEUTICALS INC has increased, with 46 insiders executing 1007 transactions across all time. Total sales of $129.8M significantly outpace purchases of $24.1M, resulting in a net outflow of $105.7M. This selling activity appears largely discretionary, which may warrant closer attention from investors.